IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.67M | -18.98M | -19.44M | -20.66M | -23.89M |
| Total Depreciation and Amortization | 2.01M | 2.33M | 2.50M | 2.68M | 2.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.16M | 2.76M | 3.19M | 3.30M | 4.42M |
| Change in Net Operating Assets | 151.00K | -648.00K | 1.04M | 72.00K | -563.00K |
| Cash from Operations | -14.36M | -14.54M | -12.71M | -14.60M | -17.19M |
| Capital Expenditure | -242.00K | -9.00K | -- | -33.00K | -33.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -242.00K | -9.00K | -- | -33.00K | -33.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -403.00K | -575.00K | -693.00K | -801.00K | -891.00K |
| Issuance of Common Stock | 19.71M | 25.21M | 29.33M | 21.96M | 21.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.00K | -88.00K | -- | 181.00K | 0.00 |
| Cash from Financing | 19.23M | 24.55M | 28.64M | 21.34M | 20.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.64M | 10.00M | 15.93M | 6.70M | 3.02M |